See every side of every news story
Get Started
SubscribeLogin
Donald Trump
Everton
Ukraine War
Volodymyr Zelenskyy
Hamas
Viktor Orbán
Israel-Hamas Conflict
Basketball
Soccer
Elon Musk
Manchester United
Premier League
Published • loading... • Updated

Anti-Factor XI Anticoagulants: Breakthrough or Bust?

Summary by Medscape
The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of anticoagulants? Medscape Medical News

1 Articles

All
Left
Center
Right
MedscapeMedscape

Anti-Factor XI Anticoagulants: Breakthrough or Bust?

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of anticoagulants? Medscape Medical News

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Friday, February 21, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical

Medical

News
For You
Search
BlindspotLocal